UCL Department of Biochemical Engineering


EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies

Training the bioprocess engineering research leaders of the future to deliver translation of new scientific advances into safely produced, more selective and affordable therapies.

The CDT is funded by the Engineering and Physical Sciences Research Council (EPSRC) and will award 7 PhD studentships a year until 2018. Each studentship is for four years and will be undertaken at UCL or one of several CDT collaborating universities. All researchers undertake 18 weeks of taught training which includes residential Summer and Autumn Camps.

Our research is at the cutting edge of process engineering and is aimed at developing new and improved processes for the next generation of biopharmaceuticals. The research is aligned to the Centre for Innovative Manufacture of Emergent Macromolecular Therapies which is also hosted at UCL. This gives all CDT students access to a consortium of key industry leaders, and an opportunity to present their work to the wider Bioprocessing community. 

The EPSRC CDT in Emergent Macromolecular Therapies recruited its final cohort of PhD students in Oct 2018.

About the CDT

The Centre For Doctoral Training (CDT) affiliated with the EPSRC Centre For Innovative Manufacturing In Emergent Macromolecular Therapies (CIMEMT) was established in May 2012. New funding was awarded in 2014 by the EPSRC for a further four cohorts (starting 2015-2018). Its focus is on manufacturing research and training required in the most rapidly developing parts of the UK bio-centred pharmaceutical and healthcare biotechnology sector, that have major implications for future medicine.

The CDT trained bioprocess engineering leaders of the future who have carried out fundamental manufacturing research that underpinned the translation of new scientific advances into safely produced, more selective, therapies for currently intractable conditions at affordable costs. CDT PhD students were embedded within the vibrant research community spanning 20 UK and 6 overseas universities, 6 National Facilities, 11 global biologics manufacturers, and the EPSRC Centre for Innovative Manufacturing (CIMEMT) hosted at UCL.  Regular presentation to the industrial partners, and attendance of CIMEMT networking events, ensured that CDT students benefitted from increased impact and knowledge transfer of their research, as well as access to relevant career opportunities. As a result, all of our graduates have entered a career directly within the sector or in related financial or consulting roles.

All projects involved collaborations with the CIMEMT, and enabled novel analytical, mathematical, computational and predictive techniques, emerging from academic laboratories across the UK, to impact on the EPSRC Centre vision. 70% of the CDT cohort was based at, or collaborating with internationally leading external Institutes.

To discuss potential research projects that could be supported by the CDT please contact Professor Paul Dalby.